| Monotherapy | Boost | P value |
---|---|---|---|
(n = 155) | (n = 63) | (t-test) | |
PV (mL) at postdosimetry | 27.8 ± 8.3 | 27.2 ± 9.4 | 0.660 |
%D90 (%) | 109.4 ± 9.7 | 113.7 ± 9.1 | 0.002 |
D90 (Gy) | 164.7 ± 16.6 | 125.1 ± 10.0 | < 0.001 |
V100 (%) | 93.3 ± 3.8 | 94.8 ± 2.8 | 0.005 |
V150 (%) | 61.5 ± 9.9 | 64.9 ± 11.0 | 0.029 |
UD30 (Gy) | 211.1 ± 28.5 | 156.0 ± 20.1 | < 0.001 |
%UD30 (%) | 140.9 ± 19.0 | 141.7 ± 18.6 | 0.784 |
R100 (mL) | 0.08 ± 0.16 | 0.11 ± 0.19 | 0.349 |
%RD30 (%) | 26.1 ± 8.1 | 27.2 ± 7.4 | 0.330 |
RD30 (Gy) | 39.9 ± 11.0 | 30.3 ± 7.4 | < 0.001 |
BED (Gy2) | 174.3 ± 18.4 | 216.1 ± 23.2 | < 0.001 |